Skip to main content
Displaying 481 - 490 of 4050
# Title Department Research Year
481 Design, synthesis, and antibacterial screening of some novel heteroaryl-based ciprofloxacin derivatives as DNA gyrase and topoisomerase IV inhibitors Department of Pharmaceutical Organic Chemistry 2021
482 Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives bearing 1,3-thiazole moiety as novel anti-inflammatory EGFR inhibitors with cardiac safety profile Department of Pharmaceutical Organic Chemistry 2021
483 Design, synthesis, and biological evaluation of novel EGFR inhibitors containing 5-chloro-3-hydroxymethyl-indole-2-carboxamide scaffold with apoptotic antiproliferative activity Department of Pharmaceutical Organic Chemistry 2021
484 Design, synthesis, biological assessment and in silico ADME prediction of new 2-(4- (methylsulfonyl) phenyl) benzimidazoles as selective cyclooxygenase-2 inhibitors 2021
485 Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Tri-Aryl Imidazole-Benzene Sulfonamide Hybrids as Promising Selective Carbonic Anhydrase IX and XII Inhibitors Department of Pharmaceutical Organic Chemistry 2021
486 Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles Department of Pharmaceutics 2021
487 Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles Department of Pharmaceutics 2021
488 Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles Department of Pharmaceutics 2021
489 Development of new hetero‑steroid hybrids with antiproliferative activity against MCF‑7 breast cancer cells Department of Pharmaceutical Organic Chemistry 2021
490 Different cellulosic polymers for synthesizing silver nanoparticles with antioxidant and antibacterial activities Department of Industrial Pharmacy 2021